Loading organizations...
§ Venture Capital · Miami, FL, USA
Private equity firm investing in UK and Ireland founder-owned SMEs, focusing on buyouts and growth capital.
Key people at Hyphacapital.
Hyphacapital is a UK-based private equity firm investing in buyouts, equity releases, and growth capital for profitable, founder-owned SMEs in the lower mid-market of the UK and Ireland, operating from offices in London and Manchester. The firm targets companies generating positive EBITDA across sectors like technology, healthcare, and advanced manufacturing, taking minority or majority positions with individual investments ranging from £3 million to £15 million. Its maiden fund, Hypha I LP, recently held its final close on approximately £120 million, surpassing its £110 million hard cap, after an initial close of £73 million. Hyphacapital plans to execute 2-3 deals annually, emphasizing close collaboration with management teams. Key personnel include partners Chris Wardle, Matt Pomroy, and Matthew Evans-Young, who previously held roles at Foresight Group. The firm was founded in 2024 by Chris Wardle, Matt Pomroy, and Matthew Evans-Young.
Key people at Hyphacapital.
Hypha Capital is a UK-based private equity firm focused on investing in founder-owned businesses within the healthcare, technology, and advanced manufacturing sectors. Their mission centers on partnering with entrepreneurial companies that have demonstrated profitability and organic growth, providing flexible capital through both majority and minority investments typically ranging from £3 million to £15 million. Hypha aims to support these businesses in scaling to become significant market players by nurturing their ambitions and leveraging experienced investor relationships[1][2][4].
Founded by partners Chris Wardle, Matt Pomroy, and Matthew Evans-Young, Hypha Capital has evolved with a clear focus on the lower mid-market in the UK and Ireland. The firm’s approach emphasizes working closely with founder-led companies that offer mission-critical products or services and have strong growth potential over the long term. Their investment strategy reflects a commitment to supporting entrepreneurial teams with a track record of success and ambition, helping them to realize their full market potential[2][5].
Hypha Capital operates at the intersection of several high-growth sectors—healthcare innovation, advanced manufacturing technologies, and digital transformation in tech. The firm’s timing aligns with increasing demand for specialized, mission-critical solutions in these areas, driven by technological advancements and evolving market needs. By focusing on founder-led companies with proven growth, Hypha helps sustain innovation and competitiveness in the UK and Irish markets, contributing to a robust startup and scale-up ecosystem that fuels broader economic development[1][4].
Looking ahead, Hypha Capital is well-positioned to capitalize on ongoing trends such as digital health expansion, Industry 4.0 manufacturing, and technology-driven service models. Their strategy of deep partnership with founder-owned businesses suggests a continued emphasis on sustainable growth and value creation rather than rapid, speculative scaling. As market dynamics evolve, Hypha’s flexible investment approach and sector expertise will likely enhance their influence, helping portfolio companies navigate challenges and seize emerging opportunities, thereby reinforcing their role as a key player in the UK’s private equity and innovation landscape[2][4].
